Disease areas:
  • clinical signs and symptoms
  • lungs
Last updated:
Author(s):
Dapeng Wang, Niran Hadad, Samuel Moss, Elena Lopez-Jimenez, Simon R Johnson, Toby M Maher, Philip L Molyneaux, Yajie Zhao, John R B Perry, Paul J Wolters, Jonathan A Kropski, R Gisli Jenkins, Nicholas E Banovich, Iain Stewart
Publish date:
10 February 2026
Journal:
BMJ Open Respiratory Research
PubMed ID:
41672577

Abstract

BACKGROUND: Pulmonary fibrosis (PF) is a rare lung disease with diverse pathogenesis and biological mechanisms. Mosaic loss of chromosome Y (mLOY) has been reported to be associated with increased risk of fibrotic diseases. However, the exact role of mLOY in the development of PF remains to be elucidated.

METHODS: Copy number on chromosome Y was used to estimate mLOY comparing patients in PROFILE and gnomAD cohorts and between cases and control patients from the GE100KGP cohort. Correlation of mLOY with demographic and clinical variables was tested using patients from the PROFILE cohort. Lung single-cell transcriptomic data were analysed to assess the cell types implicated in mLOY. Mendelian randomisation was performed to examine the causal relationship between mLOY, idiopathic pulmonary fibrosis (IPF) and telomere length.

RESULTS: The genetic analysis suggests that mLOY is found in PF from both case cohorts but when compared with an age matched population the effect is minimal (p=0.00316, median: 0.288 vs 0.291). mLOY is related to age (p=0.000214) and shorter telomere length (p=0.00815) rather than PF severity or progression. Single-cell analysis indicates that mLOY appears to be found primarily in immune cells. Mendelian randomisation demonstrates that mLOY is not on the causal pathway for IPF, but partial evidence supports that telomere shortening is on the causal pathway for mLOY.

CONCLUSIONS: Our study confirms the existence of mLOY in PF patients, suggests that mLOY is not a major driver of IPF, and might support a triangulation model where telomere shortening leads to both IPF and mLOY.

Related projects

Socioeconomic status (SES) is associated with a broad range of disease outcomes, however the specific mechanisms and nature of associations is poorly understood. Given recent…

Institution:
University of Cambridge, Great Britain

All projects